« Wal-Mart Backing Off on Organics | Main | California senate committee approves clone labeling measure »

April 12, 2007

Caruso on "How to Confine the Plants of the Future"

Denise Caruso (hybridvigor.org) published a column in the New York Times this week on the risks and challenges of genetically engineered "pharma" crops.

The plants produce medicinal substances like insulin, anticoagulants and blood substitutes. They produce vaccine proteins for diseases like cholera, as well as antibodies against tooth decay and non-Hodgkin’s lymphoma. Enzymes and other chemicals from the plants can be used for a range of industrial processes.

As in past debates over genetically modified crops, biotech developers say that the benefits outweigh the risks, and that the risks are manageable. Critics question the benefits, and say the risk of a contaminated and potentially toxic food supply is untenable.

April 12, 2007 in Biotech | Permalink


TrackBack URL for this entry:

Listed below are links to weblogs that reference Caruso on "How to Confine the Plants of the Future":


Post a comment